For more than 25 years, Marc Beer has founded and co-founded numerous biotech and pharmaceutical companies that have all become successful. He’s recognized throughout the industry for his innate ability to develop some of the most unique, workable solutions for immediate and pressing issues.
Beer graduated from Miami University in 1987 and took his B.S. in Business straight into the pharmaceutical sales and marketing industry. His first major role at a company was as Vice President of Global Marketing for Genzyme. Genzyme was the first company to benefit from Beer’s exceptional gift for promotion.
He was responsible for pushing Genzyme’s latest product line toward the more than 350 million medically underserved patients all over the world. The product line included treatments for over 7,000 rare diseases, usually overlooked by big-name pharmaceutical companies because rare diseases aren’t profitable.
After experience the gratitude from those millions of people, Beer decided he wanted to do more. Though helping other companies was also helping millions; he figured he could help more on his own terms. This was when he discovered his knack for addressing the most pressing problems in the pharmaceutical industry. Shortly after his decision to expand his horizons, he opened his first company.
In 2000, his first company, called ViaCell, put him on top of the world. ViaCell collected and preserved umbilical cord blood stem cells and used them for the development of several treatments that helped millions of people suffering from specific, rare conditions.
By 2007, Beer sold ViaCell to PerkinElmer. His first entrepreneurial sale landed him $300 million and was the first notch on his belt. As he aimed for higher goals in the future, tragedy brought him crashing back down to Earth. Later that year, Beer’s wife passed away from a pulmonary embolism.
Distraught over the loss of his wife, Beer stepped away from entrepreneurship and focused solely on his raising his three kids. He stayed away from the business for two years before his eldest daughter convinced him that he needed to go back to work. Inspired by his daughter’s wish, Beer began looking for opportunity. Learn more: https://www.prnewswire.com/news-releases/lumenxt-names-marc-beer-chairman-of-the-board-300822547.html
As if by fate, Dr. Ray Iglesias, a 35-year gynecologist, called Beer and asked for his help developing a new product. Dr. Iglesias had spent much of his career performing what he considered avoidable pelvic floor surgeries. He spent nearly ten years developing a concept, which he brought to Beer in 2016. Later that year, along with Yolanda Lorie, the trio co-founded Renovia.